2-(Piperazin-1-yl)benzo[d]thiazole hydrochloride

Catalog No.: 
ACSBLX923
CAS No.: 
35463-74-2
Molecular Formula: 
C11H14ClN3S
Molecular Weight: 
255.77
2-(Piperazin-1-yl)benzo[d]thiazole hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Piperazin-1-yl)benzo[d]thiazole hydrochloride
IUPAC Name2-(piperazin-1-yl)benzo[d]thiazole hydrochloride
Molecular FormulaC11H14ClN3S
Molecular Weight255.77
SMILES[H]Cl.C1(N2CCNCC2)=NC3=CC=CC=C3S1
InChI KeyBDUGDVVACNJZPA-UHFFFAOYSA-N
Synonym2-(piperazin-1-yl)benzo[d]thiazole(WX130439);2-(Piperazin-1-yl)benzo[d]thiazole hydrochloride
CAS No.35463-74-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACSBLX923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACQZGK630 route compound structure diagram
    ACQZGK630615-20-3In Stock
  4. Then
  5. ACSBLX923 route product structure diagram
    ACSBLX92335463-74-2
Inquiry

2. ACSBLX923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACQZGK630 route compound structure diagram
    ACQZGK630615-20-3In Stock
  6. Then
  7. ACSBLX923 route product structure diagram
    ACSBLX92335463-74-2
Inquiry

3. ACSBLX923 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBLX923 route product structure diagram
    ACSBLX92335463-74-2
Inquiry

Comments (0)